BioLife Solutions Inc. (BLFS)
BioLife Solutions Statistics
Share Statistics
BioLife Solutions has 47.5M shares outstanding. The number of shares has increased by 2.02% in one year.
| Shares Outstanding | 47.5M |
| Shares Change (YoY) | 2.02% |
| Shares Change (QoQ) | 1.32% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 45.58M |
| Failed to Deliver (FTD) Shares | 4.13K |
| FTD / Avg. Volume | 0.85% |
Short Selling Information
The latest short interest is 3.83M, so 8.26% of the outstanding shares have been sold short.
| Short Interest | 3.83M |
| Short % of Shares Out | 8.26% |
| Short % of Float | 12.2% |
| Short Ratio (days to cover) | 5.21 |
Valuation Ratios
The PE ratio is -59.25 and the forward PE ratio is 185.46. BioLife Solutions's PEG ratio is 0.83.
| PE Ratio | -59.25 |
| Forward PE | 185.46 |
| PS Ratio | 14.54 |
| Forward PS | 5.7 |
| PB Ratio | 3.43 |
| P/FCF Ratio | 229.8 |
| PEG Ratio | 0.83 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BioLife Solutions.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.54 |
| Quick Ratio | 3.66 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 16.43 |
| Debt / FCF | 4.84 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $517.32K |
| Profits Per Employee | $-126.94K |
| Employee Count | 159 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.84 |
Taxes
| Income Tax | -38K |
| Effective Tax Rate | 0.33% |
Stock Price Statistics
The stock price has increased by 35.46% in the last 52 weeks. The beta is 1.93, so BioLife Solutions's price volatility has been higher than the market average.
| Beta | 1.93 |
| 52-Week Price Change | 35.46% |
| 50-Day Moving Average | 24.3 |
| 200-Day Moving Average | 24.92 |
| Relative Strength Index (RSI) | 54.54 |
| Average Volume (20 Days) | 486.69K |
Income Statement
In the last 12 months, BioLife Solutions had revenue of 82.25M and earned -20.18M in profits. Earnings per share was -0.44.
| Revenue | 82.25M |
| Gross Profit | 57.75M |
| Operating Income | -7.13M |
| Net Income | -20.18M |
| EBITDA | 1.53M |
| EBIT | -7.13M |
| Earnings Per Share (EPS) | -0.44 |
Balance Sheet
The company has 95.39M in cash and 25.18M in debt, giving a net cash position of 70.21M.
| Cash & Cash Equivalents | 95.39M |
| Total Debt | 25.18M |
| Net Cash | 70.21M |
| Retained Earnings | 0 |
| Total Assets | 399.49M |
| Working Capital | 116.03M |
Cash Flow
In the last 12 months, operating cash flow was 8.43M and capital expenditures -3.23M, giving a free cash flow of 5.2M.
| Operating Cash Flow | 8.43M |
| Capital Expenditures | -3.23M |
| Free Cash Flow | 5.2M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 70.21%, with operating and profit margins of -8.67% and -24.54%.
| Gross Margin | 70.21% |
| Operating Margin | -8.67% |
| Pretax Margin | -13.89% |
| Profit Margin | -24.54% |
| EBITDA Margin | 1.86% |
| EBIT Margin | -8.67% |
| FCF Margin | 6.33% |
Dividends & Yields
BLFS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BLFS is $31, which is 26% higher than the current price. The consensus rating is "Buy".
| Price Target | $31 |
| Price Target Difference | 26% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Jan 29, 2014. It was a backward split with a ratio of 1:14.
| Last Split Date | Jan 29, 2014 |
| Split Type | backward |
| Split Ratio | 1:14 |
Scores
| Altman Z-Score | 13.46 |
| Piotroski F-Score | 4 |